APUS News

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

APUS

(APUS) MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of San Diego’s Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business leaders for the biopharmaceutical industry. Future Labs is part of Apimeds’ ai² innovation

September 15, 2025Partnerships
Read more →

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

APUS

MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of Alabama Culverhouse College of Business’s STEM Path to the MBA program. The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds’ ai² innovation platform, connectin

Apimeds Pharmaceuticals IPO Shares Opened For Trade At $3.60/Share; IPO Priced At $4/Share On 3.375M Shares

APUS

May 9, 2025
Read more →

Preview: Apimeds Pharmaceuticals Us, Inc Set To IPO Tomorrow

APUS

March 4, 2025
Read more →

Apimeds Pharmaceuticals Us, Inc To Start Trading Tomorrow

APUS

February 20, 2025
Read more →